MedTrace Logo

Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors

NCT01509079 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2019-06-18

Study results available
· View outcomes & findings →

Summary

The Purpose of this study is to determine whether vitamin D3 supplements will decrease the muscle and bone pain that are reported by women who take Aromatase Inhibitors.

Conditions

Interventions

DRUG

Vitamin D3

Cholecalciferol capsule, 4000IU, daily for 6 months

DRUG

Vitamin D3

cholecalciferol capsule, 600 IU, daily for 6 months

Sponsors & Collaborators

  • University of Minnesota

    collaborator OTHER

  • University of Southern California

    collaborator OTHER

  • HealthPartners Institute

    lead OTHER

Principal Investigators

  • Alice C. Shapiro, PhD RD · Park Nicollet Health Services

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-10-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01509079 on ClinicalTrials.gov